These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30506411)

  • 21. Perineural Invasion in Parotid Gland Malignancies.
    Huyett P; Duvvuri U; Ferris RL; Johnson JT; Schaitkin BM; Kim S
    Otolaryngol Head Neck Surg; 2018 Jun; 158(6):1035-1041. PubMed ID: 29337642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Parotid Malignancies—10 Years of Experience.
    Kopeć T; Mikaszewski B; Jackowska J; Waśniewska-Okupniak E; Szyfter W; Wierzbicka M
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1397-402. PubMed ID: 25850920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conservative parotidectomy for the treatment of parotid cancers.
    Lim YC; Lee SY; Kim K; Lee JS; Koo BS; Shin HA; Choi EC
    Oral Oncol; 2005 Nov; 41(10):1021-7. PubMed ID: 16129655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatic tumours of the parotid gland.
    Malata CM; Camilleri IG; McLean NR; Piggott TA; Soames JV
    Br J Oral Maxillofac Surg; 1998 Jun; 36(3):190-5. PubMed ID: 9678884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of survival in parotid adenocarcinoma not otherwise specified: a National Cancer Database study of 3155 patients.
    Zhan KY; Huang AT; Khaja SF; Bell D; Day TA
    Head Neck; 2016 Aug; 38(8):1208-12. PubMed ID: 27166875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinically Node-Negative Parotid Gland Cancers: Prognostic Factors of Survival and Surgical Extent.
    Park GC; Roh JL; Cho KJ; Jin MH; Jung YG; Lee HW; Kim TG; Choi SH; Nam SY; Kim SY
    Oncology; 2020; 98(2):102-110. PubMed ID: 31645043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of clinicopathological factors on clinical outcomes in patients with salivary gland adenoid cystic carcinoma: a multi-institutional analysis in Japan.
    Kawakita D; Murase T; Ueda K; Kano S; Tada Y; Tsukahara K; Okami K; Onitsuka T; Fujimoto Y; Matoba T; Sakurai K; Nagao T; Hanai N; Kawata R; Hato N; Nibu KI; Urano M; Taguchi KI; Nakaguro M; Kusafuka K; Yamamoto H; Nagao T; Inagaki H
    Int J Clin Oncol; 2020 Oct; 25(10):1774-1785. PubMed ID: 32613404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of lymph node metastasis of parotid cancer.
    Shinomiya H; Otsuki N; Yamashita D; Nibu K
    Auris Nasus Larynx; 2016 Aug; 43(4):446-50. PubMed ID: 26656731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and oncological outcomes after surgical excision of parotid gland tumours in patients aged over 80 years.
    Fakhry N; Aldosari B; Michel J; Giorgi R; Collet C; Santini L; Giovanni A; Dessi P
    Int J Oral Maxillofac Surg; 2013 Nov; 42(11):1385-90. PubMed ID: 23876216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic indicators in clinically node-negative malignant primary salivary tumours of the parotid: A multicentre experience.
    Fussey J; Tomasoni M; Tirelli G; Giordano L; Galli A; Colangeli R; Cazzador D; Tofanelli M; Da Mosto MC; Bianchini C; Pelucchi S; Ubayasiri K; Elsayed M; Long P; Saratziotis A; Hajiioannou J; Piazza C; Deganello A; Lombardi D; Nicolai P; Pracy P; Sharma N; Nankivell P; Borsetto D; Boscolo-Rizzo P
    Oral Oncol; 2021 Dec; 123():105577. PubMed ID: 34742011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary squamous cell carcinoma of the parotid gland.
    Lee S; Kim GE; Park CS; Choi EC; Yang WI; Lee CG; Keum KC; Kim YB; Suh CO
    Am J Otolaryngol; 2001; 22(6):400-6. PubMed ID: 11713725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic factors associated with recurrence in parotid carcinoma.
    Lee DH; Yoon TM; Lee JK; Lim SC
    Braz J Otorhinolaryngol; 2018; 84(6):691-696. PubMed ID: 28882538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes and prognostic factors for surgery followed by modern radiation therapy in parotid gland carcinomas.
    Huang BS; Chen WY; Hsieh CE; Lin CY; Lee LY; Fang KH; Tsang NM; Kang CJ; Wang HM; Chang JT
    Jpn J Clin Oncol; 2016 Sep; 46(9):832-8. PubMed ID: 27317738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of curative management of malignant tumours of the parotid gland.
    Kirkbride P; Liu FF; O'Sullivan B; Payne D; Warde P; Gullane P; Pintilie M; Keane TJ; Cummings B
    J Otolaryngol; 2001 Oct; 30(5):271-9. PubMed ID: 11771019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant epithelial parotid tumours: a rational treatment policy.
    Ball AB; Fish S; Thomas JM
    Br J Surg; 1995 May; 82(5):621-3. PubMed ID: 7613931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical-pathological prognostic factors and treatment failure patterns in T1-2 high-grade parotid gland cancer.
    Park YM; Yoon SO; Koh YW; Kim SH; Lim JY; Choi EC
    Oral Oncol; 2020 Nov; 110():104884. PubMed ID: 32629407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment and prognosis analysis of primary parotid squamous cell carcinoma].
    Yao XF; Zhang L
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Dec; 44(12):731-4. PubMed ID: 20193290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant parotid tumors. Prognostic factors and optimum treatment.
    Theriault C; Fitzpatrick PJ
    Am J Clin Oncol; 1986 Dec; 9(6):510-6. PubMed ID: 3788853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant epithelial parotid tumours.
    Ball AB; Rajagopal G; Thomas JM
    Ann R Coll Surg Engl; 1990 Jul; 72(4):247-9. PubMed ID: 2382948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant epithelial parotid gland tumours: analysis and results in 65 previously untreated patients.
    Leverstein H; van der Wal JE; Tiwari RM; Tobi H; van der Waal I; Mehta DM; Snow GB
    Br J Surg; 1998 Sep; 85(9):1267-72. PubMed ID: 9752874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.